BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Charidimou A, Boulouis G, Gurol ME, Ayata C, Bacskai BJ, Frosch MP, Viswanathan A, Greenberg SM. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain 2017;140:1829-50. [PMID: 28334869 DOI: 10.1093/brain/awx047] [Cited by in Crossref: 169] [Cited by in F6Publishing: 196] [Article Influence: 33.8] [Reference Citation Analysis]
Number Citing Articles
1 Valverde A, Mitrofanis J. Photobiomodulation for Hypertension and Alzheimer’s Disease. JAD 2022. [DOI: 10.3233/jad-220632] [Reference Citation Analysis]
2 Vázquez-Justes D, Aguirregoicoa I, Fernandez L, Carnes-Vendrell A, Dakterzada F, Sanjuan L, Mena A, Piñol-Ripoll G. Clinical impact of microbleeds in patients with Alzheimer's disease. BMC Geriatr 2022;22:774. [PMID: 36175849 DOI: 10.1186/s12877-022-03456-y] [Reference Citation Analysis]
3 Kim SE, Kim HJ, Jang H, Weiner MW, DeCarli C, Na DL, Seo SW. Interaction between Alzheimer's Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers. Int J Mol Sci 2022;23:10490. [PMID: 36142419 DOI: 10.3390/ijms231810490] [Reference Citation Analysis]
4 Che R, Zhang M, Sun H, Ma J, Hu W, Liu X, Ji X. Long-term outcome of cerebral amyloid angiopathy-related hemorrhage. CNS Neurosci Ther 2022. [PMID: 35975394 DOI: 10.1111/cns.13922] [Reference Citation Analysis]
5 Tu J, Yan J, Liu J, Liu D, Wang X, Gao F. Iron deposition in the precuneus is correlated with mild cognitive impairment in patients with cerebral microbleeds: A quantitative susceptibility mapping study. Front Neurosci 2022;16:944709. [DOI: 10.3389/fnins.2022.944709] [Reference Citation Analysis]
6 Charidimou A, Boulouis G, Frosch MP, Baron J, Pasi M, Albucher JF, Banerjee G, Barbato C, Bonneville F, Brandner S, Calviere L, Caparros F, Casolla B, Cordonnier C, Delisle M, Deramecourt V, Dichgans M, Gokcal E, Herms J, Hernandez-guillamon M, Jäger HR, Jaunmuktane Z, Linn J, Martinez-ramirez S, Martínez-sáez E, Mawrin C, Montaner J, Moulin S, Olivot J, Piazza F, Puy L, Raposo N, Rodrigues MA, Roeber S, Romero JR, Samarasekera N, Schneider JA, Schreiber S, Schreiber F, Schwall C, Smith C, Szalardy L, Varlet P, Viguier A, Wardlaw JM, Warren A, Wollenweber FA, Zedde M, van Buchem MA, Gurol ME, Viswanathan A, Al-shahi Salman R, Smith EE, Werring DJ, Greenberg SM. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study. The Lancet Neurology 2022;21:714-25. [DOI: 10.1016/s1474-4422(22)00208-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Dondi F, Bertoli M, Lucchini S, Cerudelli E, Albano D, Bertagna F. PET imaging for the evaluation of cerebral amyloid angiopathy: a systematic review. Clin Transl Imaging. [DOI: 10.1007/s40336-022-00511-x] [Reference Citation Analysis]
8 Wang Q. Editorial for "Aging Effect, Reproducibility, and Test-Retest Reliability of a New Cerebral Amyloid Angiopathy MRI Severity Marker-Cerebrovascular Reactivity to Visual Stimulation". J Magn Reson Imaging 2022. [PMID: 35838339 DOI: 10.1002/jmri.28356] [Reference Citation Analysis]
9 Taylor JL, Pritchard HAT, Walsh KR, Strangward P, White C, Hill-Eubanks D, Alakrawi M, Hennig GW, Allan SM, Nelson MT, Greenstein AS. Functionally linked potassium channel activity in cerebral endothelial and smooth muscle cells is compromised in Alzheimer's disease. Proc Natl Acad Sci U S A 2022;119:e2204581119. [PMID: 35727988 DOI: 10.1073/pnas.2204581119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Rabin JS, Nichols E, La Joie R, Casaletto KB, Palta P, Dams-O'Connor K, Kumar RG, George KM, Satizabal CL, Schneider JA, Pa J, Brickman AM. Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline. Brain 2022:awac178. [PMID: 35759327 DOI: 10.1093/brain/awac178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Wang B, Li X, Li H, Xiao L, Zhou Z, Chen K, Gui L, Hou X, Fan R, Chen K, Wu W, Li H, Hu X. Clinical, Radiological and Pathological Characteristics Between Cerebral Small Vessel Disease and Multiple Sclerosis: A Review. Front Neurol 2022;13:841521. [DOI: 10.3389/fneur.2022.841521] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rajpoot J, Crooks EJ, Irizarry BA, Amundson A, Van Nostrand WE, Smith SO. Insights into Cerebral Amyloid Angiopathy Type 1 and Type 2 from Comparisons of the Fibrillar Assembly and Stability of the Aβ40-Iowa and Aβ40-Dutch Peptides. Biochemistry 2022;61:1181-98. [PMID: 35666749 DOI: 10.1021/acs.biochem.1c00781] [Reference Citation Analysis]
13 Tian Z, Ji X, Liu J. Neuroinflammation in Vascular Cognitive Impairment and Dementia: Current Evidence, Advances, and Prospects. Int J Mol Sci 2022;23:6224. [PMID: 35682903 DOI: 10.3390/ijms23116224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tian Y, Zhao M, Chen Y, Yang M, Wang Y. The Underlying Role of the Glymphatic System and Meningeal Lymphatic Vessels in Cerebral Small Vessel Disease. Biomolecules 2022;12:748. [DOI: 10.3390/biom12060748] [Reference Citation Analysis]
15 Shaikh I, Beaulieu C, Gee M, McCreary CR, Beaudin AE, Valdés-Cabrera D, Smith EE, Camicioli R. Diffusion tensor tractography of the fornix in cerebral amyloid angiopathy, mild cognitive impairment and Alzheimer's disease. Neuroimage Clin 2022;34:103002. [PMID: 35413649 DOI: 10.1016/j.nicl.2022.103002] [Reference Citation Analysis]
16 Gupta A, Uthayaseelan K, Uthayaseelan K, Kadari M, Subhan M, Saji Parel N, Krishna PV, Sange I. Alzheimer's Disease and Stroke: A Tangled Neurological Conundrum. Cureus. [DOI: 10.7759/cureus.25005] [Reference Citation Analysis]
17 Charidimou A. Cerebrospinal Fluid Biomarkers for Cerebral Amyloid Angiopathy Diagnosis. J Alzheimers Dis 2022. [PMID: 35527557 DOI: 10.3233/JAD-220133] [Reference Citation Analysis]
18 Yang Q, Wei X, Deng B, Chang Z, Jin D, Huang Y, Zhang JH, Yenari MA, Jin K, Wang Q. Cerebral small vessel disease alters neurovascular unit regulation of microcirculation integrity involved in vascular cognitive impairment. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Vargas-george S, Dave KR. Models of cerebral amyloid angiopathy-related intracerebral hemorrhage. Brain Hemorrhages 2022. [DOI: 10.1016/j.hest.2022.05.001] [Reference Citation Analysis]
20 Marazuela P, Paez-Montserrat B, Bonaterra-Pastra A, Solé M, Hernández-Guillamon M. Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study. Int J Mol Sci 2022;23:4972. [PMID: 35563362 DOI: 10.3390/ijms23094972] [Reference Citation Analysis]
21 Jolink WMT, van Veluw SJ, Zwanenburg JJM, Rozemuller AJM, van Hecke W, Frosch MP, Bacskai BJ, Rinkel GJE, Greenberg SM, Klijn CJM. Histopathology of Cerebral Microinfarcts and Microbleeds in Spontaneous Intracerebral Hemorrhage. Transl Stroke Res 2022. [PMID: 35384634 DOI: 10.1007/s12975-022-01016-5] [Reference Citation Analysis]
22 Yang Q, Zeng X, Yu Z, Liu X, Tang L, Zhang G, Tian D, Li N, Fan D. CT-Visible Convexity Subarachnoid Hemorrhage Predicts Early Recurrence of Lobar Hemorrhage. Front Neurol 2022;13:843851. [DOI: 10.3389/fneur.2022.843851] [Reference Citation Analysis]
23 Scolding NJ. Amyloid cerebrovasculopathies. Pract Neurol. [DOI: 10.1136/practneurol-2022-003386] [Reference Citation Analysis]
24 Perosa V, Oltmer J, Munting LP, Freeze WM, Auger CA, Scherlek AA, van der Kouwe AJ, Iglesias JE, Atzeni A, Bacskai BJ, Viswanathan A, Frosch MP, Greenberg SM, van Veluw SJ. Perivascular space dilation is associated with vascular amyloid-β accumulation in the overlying cortex. Acta Neuropathol 2022;143:331-48. [PMID: 34928427 DOI: 10.1007/s00401-021-02393-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
25 Hirata Y, Kato N, Muraga K, Shindo A, Nakamura N, Matsuura K, Ii Y, Shiga M, Tabei K, Satoh M, Fukuma T, Kagawa Y, Fujita S, Kogue R, Umino M, Maeda M, Sakuma H, Dohi K, Tomimoto H. Cerebral Microbleeds With Atrial Fibrillation After Ablation Therapy. Front Cell Neurosci 2022;16:818288. [DOI: 10.3389/fncel.2022.818288] [Reference Citation Analysis]
26 Battistin U, Alqassim N, Hallak Y, Mohammed M, Hasan A, Oluwole OJ. Cerebral Amyloid Angiopathy and Atrial Fibrillation: An up to Date Case Report. The Neurohospitalist. [DOI: 10.1177/19418744211067353] [Reference Citation Analysis]
27 Jo S, Cheong E, Kim N, Oh JS, Shim WH, Kim H, Lee SJ, Lee Y, Oh M, Kim JS, Kim BJ, Roh JH, Kim SJ, Lee J, Zhu Y. Role of White Matter Abnormalities in the Relationship Between Microbleed Burden and Cognitive Impairment in Cerebral Amyloid Angiopathy. JAD 2022. [DOI: 10.3233/jad-215094] [Reference Citation Analysis]
28 Lecordier S, Pons V, Rivest S, Elali A. Multifocal Cerebral Microinfarcts Modulate Early Alzheimer’s Disease Pathology in a Sex-Dependent Manner. Front Immunol 2022;12:813536. [DOI: 10.3389/fimmu.2021.813536] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Zellner A, Müller SA, Lindner B, Beaufort N, Rozemuller AJM, Arzberger T, Gassen NC, Lichtenthaler SF, Kuster B, Haffner C, Dichgans M. Proteomic profiling in cerebral amyloid angiopathy reveals an overlap with CADASIL highlighting accumulation of HTRA1 and its substrates. Acta Neuropathol Commun 2022;10:6. [PMID: 35074002 DOI: 10.1186/s40478-021-01303-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Schwarz G, Banerjee G, Hostettler IC, Ambler G, Seiffge DJ, Ozkan H, Browning S, Simister R, Wilson D, Cohen H, Yousry T, Salman RA, Lip GYH, Brown MM, Muir KW, Houlden H, Jäger R, Werring DJ. MRI and CT imaging biomarkers of cerebral amyloid angiopathy in lobar intracerebral hemorrhage. Int J Stroke 2022;:17474930211062478. [PMID: 34994246 DOI: 10.1177/17474930211062478] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
31 Take Y, Chikai Y, Shimamori K, Kuragano M, Kurita H, Tokuraku K. Amyloid β aggregation induces human brain microvascular endothelial cell death with abnormal actin organization. Biochem Biophys Rep 2022;29:101189. [PMID: 34977364 DOI: 10.1016/j.bbrep.2021.101189] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Chang H, Ma H, Wu Y, Lee M, Chung-yueh Yuan E, Huang S, Cheng Y, Wu M, Tu L, Chan JCC. Site specific NMR characterization of abeta-40 oligomers cross seeded by abeta-42 oligomers. Chem Sci . [DOI: 10.1039/d2sc01555b] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Ward RC, Graff-radford J, Ponamgi S, English S, Meskill A, Challa AB, Hodge DO, Slusser JP, Rabinstein AA, Asirvatham SJ, Holmes D, Desimone CV. Time in therapeutic range of anticoagulation among patients with atrial fibrillation and cerebral amyloid angiopathy. Baylor University Medical Center Proceedings 2022;35:162-7. [DOI: 10.1080/08998280.2021.2013393] [Reference Citation Analysis]
34 Wang D, Wang Y, Xu D, Zhou G, He S. Relationship between uric acid and cerebral amyloid angiopathy. Int J Neurosci 2021;:1-10. [PMID: 34913811 DOI: 10.1080/00207454.2021.1903001] [Reference Citation Analysis]
35 Wu X, Ya J, Zhou D, Ding Y, Ji X, Meng R. Pathogeneses and Imaging Features of Cerebral White Matter Lesions of Vascular Origins. Aging Dis 2021;12:2031-51. [PMID: 34881084 DOI: 10.14336/AD.2021.0414] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
36 De Kort AM, Kuiperij HB, Kersten I, Versleijen AAM, Schreuder FHBM, Van Nostrand WE, Greenberg SM, Klijn CJM, Claassen JAHR, Verbeek MM. Normal cerebrospinal fluid concentrations of PDGFRβ in patients with cerebral amyloid angiopathy and Alzheimer's disease. Alzheimers Dement 2021. [PMID: 34874603 DOI: 10.1002/alz.12506] [Reference Citation Analysis]
37 Ni L, Lv W, Sun D, Sun Y, Sun Y, Xu X, Chang M, Han X, Tao S, Hu X, Cai H. Pathological Gait Signatures of Post-stroke Dementia With Toe-Off and Heel-to-Ground Angles Discriminate From Alzheimer's Disease. Front Aging Neurosci 2021;13:766884. [PMID: 34867293 DOI: 10.3389/fnagi.2021.766884] [Reference Citation Analysis]
38 Dallaire-Théroux C, Saikali S, Richer M, Potvin O, Duchesne S. Histopathological Analysis of Cerebrovascular Lesions Associated With Aging. J Neuropathol Exp Neurol 2021:nlab125. [PMID: 34875082 DOI: 10.1093/jnen/nlab125] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Kim HJ, Park D, Yun G, Kim H, Kim HG, Lee KM, Hong IK, Park KC, Lee JS, Hwang KS. Screening for cerebral amyloid angiopathy based on serological biomarkers analysis using a dielectrophoretic force-driven biosensor platform. Lab Chip 2021;21:4557-65. [PMID: 34724019 DOI: 10.1039/d1lc00742d] [Reference Citation Analysis]
40 Chen D, Roytman M, Kirou KA, Navi BB, Schweitzer AD. A case of inflammatory cerebral amyloid angiopathy after ischemic stroke - a potential risk factor related to blood-brain barrier disruption. Clin Imaging 2021;82:161-5. [PMID: 34847499 DOI: 10.1016/j.clinimag.2021.11.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Sanchez-Caro JM, de Lorenzo Martínez de Ubago I, de Celis Ruiz E, Arribas AB, Calviere L, Raposo N, Blancart RG, Fuentes B, Diez-Tejedor E, Rodriguez-Pardo J. Transient Focal Neurological Events in Cerebral Amyloid Angiopathy and the Long-term Risk of Intracerebral Hemorrhage and Death: A Systematic Review and Meta-analysis. JAMA Neurol 2021. [PMID: 34779831 DOI: 10.1001/jamaneurol.2021.3989] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
42 Onomura H, Shimizu T, Kobayashi R, Suzuki J, Nakai N, Okuda S, Ito Y. Palinopsia as an initial symptom of cerebral amyloid angiopathy-related inflammation. eNeurologicalSci 2021;25:100375. [PMID: 34765753 DOI: 10.1016/j.ensci.2021.100375] [Reference Citation Analysis]
43 Scopelliti G, Casolla B, Boulouis G, Kuchcinski G, Moulin S, Leys D, Henon H, Cordonnier C, Pasi M. Long-term neuropsychiatric symptoms in spontaneous intracerebral haemorrhage survivors. J Neurol Neurosurg Psychiatry 2021:jnnp-2021-327557. [PMID: 34728587 DOI: 10.1136/jnnp-2021-327557] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
44 Parfenov VA, Kulesh AA. [Cerebrovascular disease with neurocognitive impairment]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:121-30. [PMID: 34693700 DOI: 10.17116/jnevro2021121091121] [Reference Citation Analysis]
45 Ono K, Watanabe-Nakayama T. Aggregation and structure of amyloid β-protein. Neurochem Int 2021;151:105208. [PMID: 34655726 DOI: 10.1016/j.neuint.2021.105208] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
46 Maniskas ME, Mack AF, Morales-Scheihing D, Finger C, Zhu L, Paulter R, Urayama A, McCullough LD, Manwani B. Sex differences in a murine model of Cerebral Amyloid Angiopathy. Brain Behav Immun Health 2021;14:100260. [PMID: 34589766 DOI: 10.1016/j.bbih.2021.100260] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Ii Y, Ishikawa H, Matsuyama H, Shindo A, Matsuura K, Yoshimaru K, Satoh M, Taniguchi A, Matsuda K, Umino M, Maeda M, Tomimoto H. Hypertensive Arteriopathy and Cerebral Amyloid Angiopathy in Patients with Cognitive Decline and Mixed Cerebral Microbleeds. J Alzheimers Dis 2020;78:1765-74. [PMID: 33185609 DOI: 10.3233/JAD-200992] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Lecordier S, Manrique-Castano D, El Moghrabi Y, ElAli A. Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors. Front Aging Neurosci 2021;13:727590. [PMID: 34566627 DOI: 10.3389/fnagi.2021.727590] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
49 Wagner A, Groetsch C, Wilfling S, Schebesch KM, Kilic M, Nenkov M, Wendl C, Linker RA, Schlachetzki F. Index event of cerebral amyloid angiopathy (CAA) determines long-term prognosis and recurrent events (retrospective analysis and clinical follow-up). Neurol Res Pract 2021;3:51. [PMID: 34565480 DOI: 10.1186/s42466-021-00152-x] [Reference Citation Analysis]
50 Marazuela P, Solé M, Bonaterra-Pastra A, Pizarro J, Camacho J, Martínez-Sáez E, Kuiperij HB, Verbeek MM, de Kort AM, Schreuder FHBM, Klijn CJM, Castillo-Ribelles L, Pancorbo O, Rodríguez-Luna D, Pujadas F, Delgado P, Hernández-Guillamon M. MFG-E8 (LACTADHERIN): a novel marker associated with cerebral amyloid angiopathy. Acta Neuropathol Commun 2021;9:154. [PMID: 34530925 DOI: 10.1186/s40478-021-01257-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Perosa V, Scherlek AA, Kozberg MG, Smith L, Westerling-Bui T, Auger CA, Vasylechko S, Greenberg SM, van Veluw SJ. Deep learning assisted quantitative assessment of histopathological markers of Alzheimer's disease and cerebral amyloid angiopathy. Acta Neuropathol Commun 2021;9:141. [PMID: 34419154 DOI: 10.1186/s40478-021-01235-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
52 Okamoto N, Ikenouchi A, Seki I, Hirano N, Yoshimura R. Cerebral Amyloid Angiopathy With a Hypomanic Episode Treated With Valproic Acid. Cureus 2021;13:e16411. [PMID: 34408959 DOI: 10.7759/cureus.16411] [Reference Citation Analysis]
53 Zarini-Gakiye E, Amini J, Sanadgol N, Vaezi G, Parivar K. Recent Updates in the Alzheimer's Disease Etiopathology and Possible Treatment Approaches: A Narrative Review of Current Clinical Trials. Curr Mol Pharmacol 2020;13:273-94. [PMID: 32321414 DOI: 10.2174/1874467213666200422090135] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
54 Robinson JL, Richardson H, Xie SX, Suh E, Van Deerlin VM, Alfaro B, Loh N, Porras-Paniagua M, Nirschl JJ, Wolk D, Lee VM, Lee EB, Trojanowski JQ. The development and convergence of co-pathologies in Alzheimer's disease. Brain 2021;144:953-62. [PMID: 33449993 DOI: 10.1093/brain/awaa438] [Cited by in Crossref: 2] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
55 Bravo GÁ, Cirera LS, Torrentà LR. Clinical and radiological features of cerebral amyloid angiopathy-related inflammation. Neurol Sci 2021. [PMID: 34374865 DOI: 10.1007/s10072-021-05490-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Wagner A, Maderer J, Wilfling S, Kaiser J, Kilic M, Linker RA, Schebesch KM, Schlachetzki F. Cerebrovascular Risk Factors in Possible or Probable Cerebral Amyloid Angiopathy, Modifier or Bystander? Front Neurol 2021;12:676931. [PMID: 34354659 DOI: 10.3389/fneur.2021.676931] [Reference Citation Analysis]
57 Oh CH, Lee JS. Innumerable cerebral microbleeds in hepatitis B virus-related decompensated liver cirrhosis: a case report. BMC Neurol 2021;21:245. [PMID: 34172015 DOI: 10.1186/s12883-021-02291-9] [Reference Citation Analysis]
58 Patel AG, Nehete PN, Krivoshik SR, Pei X, Cho EL, Nehete BP, Ramani MD, Shao Y, Williams LE, Wisniewski T, Scholtzova H. Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys. Brain 2021:awab129. [PMID: 34128045 DOI: 10.1093/brain/awab129] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
59 Stovicek PO, Friedmann C, Marinescu D, Văduva IA, Bondari S, Trifu SC, Marinescu I. Mild TBI in the elderly - risk factor for rapid cognitive impairment in Alzheimer's disease. Rom J Morphol Embryol 2020;61:61-72. [PMID: 32747896 DOI: 10.47162/RJME.61.1.07] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Chantran Y, Capron J, Doukhi D, Felix J, Féroul M, Kruse F, Chaigneau T, Dorothée G, Allou T, Ayrignac X, Barrou Z, de Broucker T, Cret C, Turc G, Peres R, Wacongne A, Sarazin M, Renard D, Cordonnier C, Alamowitch S, Aucouturier P. Letter to the editor: Serum anti-Aβ antibodies in cerebral amyloid angiopathy. Autoimmun Rev 2021;20:102870. [PMID: 34118456 DOI: 10.1016/j.autrev.2021.102870] [Reference Citation Analysis]
61 Solis E Jr., Hascup KN, Hascup ER. Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction. J Alzheimers Dis 2020;76:1179-98. [PMID: 32597813 DOI: 10.3233/JAD-200473] [Cited by in Crossref: 12] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
62 Candelise N, Scaricamazza S, Salvatori I, Ferri A, Valle C, Manganelli V, Garofalo T, Sorice M, Misasi R. Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications. Int J Mol Sci 2021;22:6016. [PMID: 34199513 DOI: 10.3390/ijms22116016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
63 Bir SC, Khan MW, Javalkar V, Toledo EG, Kelley RE. Emerging Concepts in Vascular Dementia: A Review. J Stroke Cerebrovasc Dis 2021;30:105864. [PMID: 34062312 DOI: 10.1016/j.jstrokecerebrovasdis.2021.105864] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
64 Mattavelli D, Mele F, Bertora P, Rosa S, Bortolami C, Nascimbene C, Osio M, Pantoni L. Epileptiform Activity During Transient Focal Neurologic Episodes in Cerebral Amyloid Angiopathy. Neurol Clin Pract 2021;11:e43-5. [PMID: 33968493 DOI: 10.1212/CPJ.0000000000000781] [Reference Citation Analysis]
65 Ruiz-Riquelme A, Mao A, Barghash MM, Lau HHC, Stuart E, Kovacs GG, Nilsson KPR, Fraser PE, Schmitt-Ulms G, Watts JC. Aβ43 aggregates exhibit enhanced prion-like seeding activity in mice. Acta Neuropathol Commun 2021;9:83. [PMID: 33971978 DOI: 10.1186/s40478-021-01187-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
66 Creekmore BC, Chang YW, Lee EB. The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Aggregates. J Neuropathol Exp Neurol 2021;80:514-29. [PMID: 33970243 DOI: 10.1093/jnen/nlab039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
67 Zhang X, O'Callaghan P, Li H, Tan Y, Zhang G, Barash U, Wang X, Lannfelt L, Vlodavsky I, Lindahl U, Li JP. Heparanase overexpression impedes perivascular clearance of amyloid-β from murine brain: relevance to Alzheimer's disease. Acta Neuropathol Commun 2021;9:84. [PMID: 33971986 DOI: 10.1186/s40478-021-01182-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Graff-Radford J, Lesnick TG, Mielke MM, Constantopoulos E, Rabinstein AA, Przybelski SA, Vemuri P, Botha H, Jones DT, Ramanan VK, Petersen RC, Knopman DS, Boeve BF, Murray ME, Dickson DW, Jack CR, Kantarci K, Reichard RR. Cerebral Amyloid Angiopathy Burden and Cerebral Microbleeds: Pathological Evidence for Distinct Phenotypes. J Alzheimers Dis 2021;81:113-22. [PMID: 33720897 DOI: 10.3233/JAD-201536] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
69 Ishikawa H, Niwa A, Kato S, Ii Y, Shindo A, Matsuura K, Nishiguchi Y, Tamura A, Taniguchi A, Maeda M, Hashizume Y, Tomimoto H. Micro-MRI improves the accuracy of clinical diagnosis in cerebral small vessel disease. Brain Commun 2021;3:fcab070. [PMID: 33997783 DOI: 10.1093/braincomms/fcab070] [Reference Citation Analysis]
70 Sakai K, Noguchi-Shinohara M, Ikeda T, Hamaguchi T, Ono K, Yamada M. Cerebrospinal fluid cytokines and metalloproteinases in cerebral amyloid angiopathy-related inflammation. Acta Neurol Scand 2021;143:450-7. [PMID: 33247941 DOI: 10.1111/ane.13382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Palaiodimou L, Theodorou A, Lachanis S, Paraskevas GP, Papathanasiou M, Zompola C, Voumvourakis KI, Tsivgoulis G. Stopping "transient ischemic attacks" by antiplatelet withdrawal. Neurol Res Pract 2021;3:19. [PMID: 33789747 DOI: 10.1186/s42466-021-00117-0] [Reference Citation Analysis]
72 Elarjani T, Alamer OB, Dababo M, Hassounah M. Innumerable hemorrhagic brain metastases from a neuroendocrine tumor grade-1 with prolonged natural history. Int J Surg Case Rep 2021;82:105855. [PMID: 33839631 DOI: 10.1016/j.ijscr.2021.105855] [Reference Citation Analysis]
73 Unzeta M, Hernàndez-Guillamon M, Sun P, Solé M. SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease. Int J Mol Sci 2021;22:3365. [PMID: 33805974 DOI: 10.3390/ijms22073365] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
74 de Falco A, De Simone M, d'Onofrio F, Spitaleri D, de Falco FA. Perfusion-weighted MRI in cerebral amyloid angiopathy-related transient focal neurological episodes. Neurol Sci 2021;42:3419-22. [PMID: 33754233 DOI: 10.1007/s10072-021-05195-1] [Reference Citation Analysis]
75 Chatterjee P, Tegg M, Pedrini S, Fagan AM, Xiong C, Singh AK, Taddei K, Gardener S, Masters CL, Schofield PR, Multhaup G, Benzinger TLS, Morris JC, Bateman RJ, Greenberg SM, van Buchem MA, Stoops E, Vanderstichele H, Teunissen CE, Hankey GJ, Wermer MJH, Sohrabi HR, Martins RN, The Dominantly Inherited Alzheimer Network. Plasma Amyloid-Beta Levels in a Pre-Symptomatic Dutch-Type Hereditary Cerebral Amyloid Angiopathy Pedigree: A Cross-Sectional and Longitudinal Investigation. Int J Mol Sci 2021;22:2931. [PMID: 33805778 DOI: 10.3390/ijms22062931] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
76 Mukherjee S, Perez KA, Lago LC, Klatt S, McLean CA, Birchall IE, Barnham KJ, Masters CL, Roberts BR. Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer's disease. Brain Commun 2021;3:fcab028. [PMID: 33928245 DOI: 10.1093/braincomms/fcab028] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
77 Sporns PB, Psychogios MN, Boulouis G, Charidimou A, Li Q, Fainardi E, Dowlatshahi D, Goldstein JN, Morotti A. Neuroimaging of Acute Intracerebral Hemorrhage. J Clin Med 2021;10:1086. [PMID: 33807843 DOI: 10.3390/jcm10051086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Raposo N, Zanon Zotin MC, Schoemaker D, Xiong L, Fotiadis P, Charidimou A, Pasi M, Boulouis G, Schwab K, Schirmer MD, Etherton MR, Gurol ME, Greenberg SM, Duering M, Viswanathan A. Peak Width of Skeletonized Mean Diffusivity as Neuroimaging Biomarker in Cerebral Amyloid Angiopathy. AJNR Am J Neuroradiol 2021;42:875-81. [PMID: 33664113 DOI: 10.3174/ajnr.A7042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
79 Marazuela P, Bonaterra-Pastra A, Faura J, Penalba A, Pizarro J, Pancorbo O, Rodríguez-Luna D, Vert C, Rovira A, Pujadas F, Freijo MM, Tur S, Martínez-Zabaleta M, Cardona Portela P, Vera R, Lebrato-Hernández L, Arenillas JF, Pérez-Sánchez S, Montaner J, Delgado P, Hernández-Guillamon M. Circulating AQP4 Levels in Patients with Cerebral Amyloid Angiopathy-Associated Intracerebral Hemorrhage. J Clin Med 2021;10:989. [PMID: 33801197 DOI: 10.3390/jcm10050989] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
80 Zanon Zotin MC, Sveikata L, Viswanathan A, Yilmaz P. Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management. Curr Opin Neurol 2021;34:246-57. [PMID: 33630769 DOI: 10.1097/WCO.0000000000000913] [Cited by in Crossref: 2] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
81 Lai AY, Joo IL, Trivedi AU, Dorr A, Hill ME, Stefanovic B, McLaurin J. Cerebrovascular damage after midlife transient hypertension in non-transgenic and Alzheimer's disease rats. Brain Res 2021;1758:147369. [PMID: 33582120 DOI: 10.1016/j.brainres.2021.147369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
82 Bersano A; SENECA study. Authors' reply to Bugiani O: More focus on SENECA with CAA. Neurol Sci 2021;42:2589-90. [PMID: 33523321 DOI: 10.1007/s10072-021-05092-7] [Reference Citation Analysis]
83 Pinho J, Araújo JM, Costa AS, Silva F, Francisco A, Quintas-Neves M, Soares-Fernandes J, Ferreira C, Oliveira TG. Intracerebral Hemorrhage Recurrence in Patients with and without Cerebral Amyloid Angiopathy. Cerebrovasc Dis Extra 2021;11:15-21. [PMID: 33503633 DOI: 10.1159/000513503] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
84 Fu Z, Van Nostrand WE, Smith SO. Anti-Parallel β-Hairpin Structure in Soluble Aβ Oligomers of Aβ40-Dutch and Aβ40-Iowa. Int J Mol Sci 2021;22:1225. [PMID: 33513738 DOI: 10.3390/ijms22031225] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
85 Bonaterra-Pastra A, Fernández-de-Retana S, Rivas-Urbina A, Puig N, Benítez S, Pancorbo O, Rodríguez-Luna D, Pujadas F, Freijo MDM, Tur S, Martínez-Zabaleta M, Cardona Portela P, Vera R, Lebrato-Hernández L, Arenillas JF, Pérez-Sánchez S, Montaner J, Sánchez-Quesada JL, Hernández-Guillamon M. Comparison of Plasma Lipoprotein Composition and Function in Cerebral Amyloid Angiopathy and Alzheimer's Disease. Biomedicines 2021;9:72. [PMID: 33445800 DOI: 10.3390/biomedicines9010072] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
86 Li N, Zhang X, Gu Z, Su C, Lian H. Young plasma attenuates cognitive impairment and the cortical hemorrhage area in cerebral amyloid angiopathy model mice. Ann Transl Med 2021;9:147. [PMID: 33569449 DOI: 10.21037/atm-20-8008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
87 Young KZ, Xu G, Keep SG, Borjigin J, Wang MM. Overlapping Protein Accumulation Profiles of CADASIL and CAA: Is There a Common Mechanism Driving Cerebral Small-Vessel Disease? Am J Pathol 2020:S0002-9440(20)30597-6. [PMID: 33387456 DOI: 10.1016/j.ajpath.2020.11.015] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
88 Drenth N, van der Grond J, Rombouts SARB, van Buchem MA, Terwindt GM, Wermer MJH, Chhatwal JP, Gurol ME, Greenberg SM, van Rooden S. Cerebral amyloid angiopathy is associated with decreased functional brain connectivity. Neuroimage Clin 2021;29:102546. [PMID: 33421870 DOI: 10.1016/j.nicl.2020.102546] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 Rost NS, Etherton M. Cerebral Small Vessel Disease. Continuum (Minneap Minn) 2020;26:332-52. [PMID: 32224755 DOI: 10.1212/CON.0000000000000841] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
90 Meschia JF. Predicting Who Will Experience Cerebral Hemorrhage When Anticoagulated. Mayo Clin Proc 2020;95:2057-9. [PMID: 33012334 DOI: 10.1016/j.mayocp.2020.08.025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
91 Scheumann V, Schreiber F, Perosa V, Assmann A, Mawrin C, Garz C, Heinze HJ, Görtler M, Düzel E, Vielhaber S, Charidimou A, Schreiber S. MRI phenotyping of underlying cerebral small vessel disease in mixed hemorrhage patients. J Neurol Sci 2020;419:117173. [PMID: 33068905 DOI: 10.1016/j.jns.2020.117173] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
92 Cortes-Canteli M, Iadecola C. Alzheimer's Disease and Vascular Aging: JACC Focus Seminar. J Am Coll Cardiol 2020;75:942-51. [PMID: 32130930 DOI: 10.1016/j.jacc.2019.10.062] [Cited by in Crossref: 40] [Cited by in F6Publishing: 79] [Article Influence: 20.0] [Reference Citation Analysis]
93 Parodi-Rullán R, Sone JY, Fossati S. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease. J Alzheimers Dis 2019;72:1019-39. [PMID: 31306129 DOI: 10.3233/JAD-190357] [Cited by in Crossref: 23] [Cited by in F6Publishing: 34] [Article Influence: 11.5] [Reference Citation Analysis]
94 Ii Y, Ishikawa H, Shindo A, Matsuyama H, Matsuura K, Matsuda K, Yoshimaru K, Satoh M, Kogue R, Umino M, Maeda M, Tomimoto H. Association between cortical microinfarcts and total small vessel disease burden in cerebral amyloid angiopathy on 3-Tesla magnetic resonance imaging. Eur J Neurol 2021;28:794-9. [PMID: 33098163 DOI: 10.1111/ene.14610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Gireud-Goss M, Mack AF, McCullough LD, Urayama A. Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction. Neuroscientist 2020;:1073858420954811. [PMID: 33238806 DOI: 10.1177/1073858420954811] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
96 Kim SH, Ahn JH, Yang H, Lee P, Koh GY, Jeong Y. Cerebral amyloid angiopathy aggravates perivascular clearance impairment in an Alzheimer's disease mouse model. Acta Neuropathol Commun 2020;8:181. [PMID: 33153499 DOI: 10.1186/s40478-020-01042-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
97 Lee JS, Lee H, Park S, Choe Y, Park YH, Cheon BK, Hahn A, Ossenkoppele R, Kim HJ, Kim S, Yoo H, Jang H, Cho SH, Kim SJ, Kim JP, Jung YH, Park KC, DeCarli C, Weiner MW, Na DL, Seo SW. Association between APOE ε2 and Aβ burden in patients with Alzheimer- and vascular-type cognitive impairment. Neurology 2020;95:e2354-65. [PMID: 32928967 DOI: 10.1212/WNL.0000000000010811] [Reference Citation Analysis]
98 Ward R, Ponamgi S, Desimone CV, English S, Hodge DO, Slusser JP, Graff-radford J, Rabinstein AA, Asirvatham SJ, Holmes D. Utility of HAS-BLED and CHA2DS2-VASc Scores Among Patients With Atrial Fibrillation and Imaging Evidence of Cerebral Amyloid Angiopathy. Mayo Clinic Proceedings 2020;95:2090-8. [DOI: 10.1016/j.mayocp.2020.03.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
99 Frol S, Šabovič M, Oblak JP. Re-initiation of anticoagulation after central nervous system hemorrhage during treatment with direct oral anticoagulants: a single hospital cohort study. Neurol Sci 2021;42:2005-12. [PMID: 32995994 DOI: 10.1007/s10072-020-04776-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Rajdev K, Mehan S. Neuroprotective Methodologies of Co-Enzyme Q10 Mediated Brain Hemorrhagic Treatment: Clinical and Pre-Clinical Findings. CNS Neurol Disord Drug Targets 2019;18:446-65. [PMID: 31187715 DOI: 10.2174/1871527318666190610101144] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
101 Ibrahim MA, Haleem M, AbdelWahab SA, Abdel-Aziz AM. Sildenafil ameliorates Alzheimer disease via the modulation of vascular endothelial growth factor and vascular cell adhesion molecule-1 in rats. Hum Exp Toxicol 2021;40:596-607. [PMID: 32959702 DOI: 10.1177/0960327120960775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
102 Fischer P, Sugimoto K, Chung DY, Tamim I, Morais A, Takizawa T, Qin T, Gomez CA, Schlunk F, Endres M, Yaseen MA, Sakadzic S, Ayata C. Rapid hematoma growth triggers spreading depolarizations in experimental intracortical hemorrhage. J Cereb Blood Flow Metab 2021;41:1264-76. [PMID: 32936730 DOI: 10.1177/0271678X20951993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
103 Best JG, Barbato C, Ambler G, Du H, Banerjee G, Wilson D, Shakeshaft C, Cohen H, Yousry TA, Al-Shahi Salman R, Lip GYH, Houlden H, Brown MM, Muir KW, Jäger HR, Werring DJ; Clinical Relevance of Microbleeds in Stroke (CROMIS-2) collaborators. Association of enlarged perivascular spaces and anticoagulant-related intracranial hemorrhage. Neurology 2020;95:e2192-9. [PMID: 32934168 DOI: 10.1212/WNL.0000000000010788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
104 Gupta VB, Chitranshi N, den Haan J, Mirzaei M, You Y, Lim JK, Basavarajappa D, Godinez A, Di Angelantonio S, Sachdev P, Salekdeh GH, Bouwman F, Graham S, Gupta V. Retinal changes in Alzheimer's disease- integrated prospects of imaging, functional and molecular advances. Prog Retin Eye Res 2021;82:100899. [PMID: 32890742 DOI: 10.1016/j.preteyeres.2020.100899] [Cited by in Crossref: 10] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
105 Goetzl EJ. Advancing medicine for Alzheimer's disease: A plasma neural exosome platform. FASEB J 2020;34:13079-84. [PMID: 32856798 DOI: 10.1096/fj.202001655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
106 Finsterwalder S, Vlegels N, Gesierich B, Araque Caballero MÁ, Weaver NA, Franzmeier N, Georgakis MK, Konieczny MJ, Koek HL, Karch CM, Graff-Radford NR, Salloway S, Oh H, Allegri RF, Chhatwal JP, Jessen F, Düzel E, Dobisch L, Metzger C, Peters O, Incesoy EI, Priller J, Spruth EJ, Schneider A, Fließbach K, Buerger K, Janowitz D, Teipel SJ, Kilimann I, Laske C, Buchmann M, Heneka MT, Brosseron F, Spottke A, Roy N, Ertl-Wagner B, Scheffler K, Seo SW, Kim Y, Na DL, Kim HJ, Jang H, Ewers M, Levin J, Schmidt R, Pasternak O, Dichgans M, Biessels GJ, Duering M; Dominantly Inherited Alzheimer Network (DIAN)., DELCODE study group., Alzheimer's Disease Neuroimaging Initiative (ADNI)., Utrecht VCI study group. Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patients. Alzheimers Dement 2020;16:1504-14. [PMID: 32808747 DOI: 10.1002/alz.12150] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
107 Lee H, Xu F, Liu X, Koundal S, Zhu X, Davis J, Yanez D, Schrader J, Stanisavljevic A, Rothman DL, Wardlaw J, Van Nostrand WE, Benveniste H. Diffuse white matter loss in a transgenic rat model of cerebral amyloid angiopathy. J Cereb Blood Flow Metab 2021;41:1103-18. [PMID: 32791876 DOI: 10.1177/0271678X20944226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
108 Puy L, Hochart A, Moulin S, Cordonnier C. Angiopatia amiloide cerebrale sporadica. EMC - Neurologia 2020;20:1-11. [DOI: 10.1016/s1634-7072(20)44005-x] [Reference Citation Analysis]
109 Ayrignac X, Gaillard N, Carra-Dallière C, Labauge P. Microangiopathie cérébrale: du diagnostic à la prise en charge small vessel disease of the brain: Diagnosis and management. Rev Med Interne 2020;41:469-74. [PMID: 32718708 DOI: 10.1016/j.revmed.2020.04.018] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
110 Perosa V, Priester A, Ziegler G, Cardenas-Blanco A, Dobisch L, Spallazzi M, Assmann A, Maass A, Speck O, Oltmer J, Heinze HJ, Schreiber S, Düzel E. Hippocampal vascular reserve associated with cognitive performance and hippocampal volume. Brain 2020;143:622-34. [PMID: 31994699 DOI: 10.1093/brain/awz383] [Cited by in Crossref: 32] [Cited by in F6Publishing: 42] [Article Influence: 16.0] [Reference Citation Analysis]
111 Fotiadis P, Reijmer YD, Van Veluw SJ, Martinez-Ramirez S, Karahanoglu FI, Gokcal E, Schwab KM, Goldstein JN, Rosand J, Viswanathan A, Greenberg SM, Gurol ME; Alzheimer's Disease Neuroimaging Initiative study group. White matter atrophy in cerebral amyloid angiopathy. Neurology 2020;95:e554-62. [PMID: 32611644 DOI: 10.1212/WNL.0000000000010017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
112 Groeneveld ON, Moneti C, Heinen R, de Bresser J, Kuijf HJ, Exalto LG, Boomsma JMF, Kappelle LJ, Barkhof F, Prins ND, Scheltens P, van der Flier WM, Biessels GJ; TRACE-VCI study group. The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus. J Alzheimers Dis 2019;68:311-22. [PMID: 30775988 DOI: 10.3233/JAD-180914] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
113 Ouin E, Jouvent E. [Clinico-radiological spectrum of cerebral small vessel diseases]. Rev Med Interne 2020;41:459-68. [PMID: 32540119 DOI: 10.1016/j.revmed.2020.02.013] [Reference Citation Analysis]
114 McCreary CR, Beaudin AE, Subotic A, Zwiers AM, Alvarez A, Charlton A, Goodyear BG, Frayne R, Smith EE. Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy. Neuroimage Clin 2020;27:102280. [PMID: 32521475 DOI: 10.1016/j.nicl.2020.102280] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
115 Gatti L, Tinelli F, Scelzo E, Arioli F, Di Fede G, Obici L, Pantoni L, Giaccone G, Caroppo P, Parati EA, Bersano A. Understanding the Pathophysiology of Cerebral Amyloid Angiopathy. Int J Mol Sci 2020;21:E3435. [PMID: 32414028 DOI: 10.3390/ijms21103435] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
116 Roy M, Pal I, Nath AK, Dey SG. Peroxidase activity of heme bound amyloid β peptides associated with Alzheimer's disease. Chem Commun (Camb) 2020;56:4505-18. [PMID: 32297620 DOI: 10.1039/c9cc09758a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
117 Pongpitakmetha T, Fotiadis P, Pasi M, Boulouis G, Xiong L, Warren AD, Schwab KM, Rosand J, Gurol ME, Greenberg SM, Viswanathan A, Charidimou A. Cortical superficial siderosis progression in cerebral amyloid angiopathy: Prospective MRI study. Neurology 2020;94:e1853-65. [PMID: 32284360 DOI: 10.1212/WNL.0000000000009321] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
118 Dewey CW, Rishniw M, Johnson PJ, Davies ES, Sackman JJ, O'Donnell M, Platt S, Robinson K. Interthalamic adhesion size in aging dogs with presumptive spontaneous brain microhemorrhages: a comparative retrospective MRI study of dogs with and without evidence of canine cognitive dysfunction. PeerJ 2020;8:e9012. [PMID: 32322448 DOI: 10.7717/peerj.9012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
119 Oikari LE, Pandit R, Stewart R, Cuní-López C, Quek H, Sutharsan R, Rantanen LM, Oksanen M, Lehtonen S, de Boer CM, Polo JM, Götz J, Koistinaho J, White AR. Altered Brain Endothelial Cell Phenotype from a Familial Alzheimer Mutation and Its Potential Implications for Amyloid Clearance and Drug Delivery. Stem Cell Reports 2020;14:924-39. [PMID: 32275861 DOI: 10.1016/j.stemcr.2020.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 5.5] [Reference Citation Analysis]
120 Tang BL. Neuropathological Mechanisms Associated with Pesticides in Alzheimer's Disease. Toxics 2020;8:E21. [PMID: 32218337 DOI: 10.3390/toxics8020021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
121 Tanaka M, Saito S, Inoue T, Satoh-Asahara N, Ihara M. Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease. Int J Mol Sci 2020;21:E1992. [PMID: 32183348 DOI: 10.3390/ijms21061992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
122 Morrone CD, Bishay J, McLaurin J. Potential Role of Venular Amyloid in Alzheimer's Disease Pathogenesis. Int J Mol Sci 2020;21:E1985. [PMID: 32183293 DOI: 10.3390/ijms21061985] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
123 Bersano A, Scelzo E, Pantoni L, Morotti A, Erbetta A, Chiapparini L, Vitali P, Giaccone G, Caroppo P, Catania M, Obici L, Di Fede G, Gatti L, Tinelli F, Di Francesco JC, Piazza F, Ferrarese C, Gasparini M, Adobbati L, Bianchi-Marzoli S, Tremolada G, Sacco S, Mancuso M, Zedde ML, Godani M, Lanfranconi S, Pareyson D, Di Girolamo M, Motto C, Charidimou A, Boulouis G, Parati EA; SENECA project. Discovering the Italian phenotype of cerebral amyloid angiopathy (CAA): the SENECA project. Neurol Sci 2020;41:2193-200. [PMID: 32166471 DOI: 10.1007/s10072-020-04306-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
124 Hao Q, Tsankova NM, Shoirah H, Kellner CP, Nael K. Vessel Wall MRI Enhancement in Noninflammatory Cerebral Amyloid Angiopathy. AJNR Am J Neuroradiol 2020;41:446-8. [PMID: 32139424 DOI: 10.3174/ajnr.A6445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
125 Nehete PN, Williams LE, Chitta S, Nehete BP, Patel AG, Ramani MD, Wisniewski T, Scholtzova H. Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis). Front Aging Neurosci 2020;12:36. [PMID: 32194391 DOI: 10.3389/fnagi.2020.00036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
126 Baldacci F, Mazzucchi S, Della Vecchia A, Giampietri L, Giannini N, Koronyo-Hamaoui M, Ceravolo R, Siciliano G, Bonuccelli U, Elahi FM, Vergallo A, Lista S, Giorgi FS, Hampel H. The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases. Expert Rev Mol Diagn 2020;20:421-41. [PMID: 32066283 DOI: 10.1080/14737159.2020.1731306] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
127 Kulesh AA, Gorst NK, Kuzina NV, Drobakha VE, Shestakov VV, Karakulova YV. Amyloid angiitis and progressive cortical superficial siderosis as aggressive phenotypes of cerebral amyloid angiopathy: principles of rational management. РНЖ 2020;24:29-38. [DOI: 10.30629/2658-7947-2019-24-6-29-38] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
128 Pasi M, Cordonnier C. Clinical Relevance of Cerebral Small Vessel Diseases. Stroke 2020;51:47-53. [DOI: 10.1161/strokeaha.119.024148] [Cited by in Crossref: 22] [Cited by in F6Publishing: 31] [Article Influence: 11.0] [Reference Citation Analysis]
129 Yilmaz P, Ikram MA, Ikram MK, Niessen WJ, Viswanathan A, Charidimou A, Vernooij MW. Application of an Imaging-Based Sum Score for Cerebral Amyloid Angiopathy to the General Population: Risk of Major Neurological Diseases and Mortality. Front Neurol 2019;10:1276. [PMID: 31866930 DOI: 10.3389/fneur.2019.01276] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
130 van Veluw SJ, Hou SS, Calvo-Rodriguez M, Arbel-Ornath M, Snyder AC, Frosch MP, Greenberg SM, Bacskai BJ. Vasomotion as a Driving Force for Paravascular Clearance in the Awake Mouse Brain. Neuron 2020;105:549-561.e5. [PMID: 31810839 DOI: 10.1016/j.neuron.2019.10.033] [Cited by in Crossref: 62] [Cited by in F6Publishing: 92] [Article Influence: 20.7] [Reference Citation Analysis]
131 Goulay R, Mena Romo L, Hol EM, Dijkhuizen RM. From Stroke to Dementia: a Comprehensive Review Exposing Tight Interactions Between Stroke and Amyloid-β Formation. Transl Stroke Res 2020;11:601-14. [PMID: 31776837 DOI: 10.1007/s12975-019-00755-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 44] [Article Influence: 9.3] [Reference Citation Analysis]
132 Bermejo-guerrero L, Sánchez-tejerina D, Sánchez-tornero M, Sánchez-sánchez MDC, Gómez-grande A, Villarejo-galende A, Herrero-san Martín AO, González-sánchez M, Masters C. Low Amyloid-PET Uptake in Iowa-Type Cerebral Amyloid Angiopathy with Cerebral Venous Thrombosis. JAD 2019;72:677-81. [DOI: 10.3233/jad-190800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
133 Haffner C. Proteostasis in Cerebral Small Vessel Disease. Front Neurosci 2019;13:1142. [PMID: 31798396 DOI: 10.3389/fnins.2019.01142] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
134 Charidimou A, Boulouis G, Greenberg SM, Viswanathan A. Cortical superficial siderosis and bleeding risk in cerebral amyloid angiopathy: A meta-analysis. Neurology 2019;93:e2192-202. [PMID: 31732564 DOI: 10.1212/WNL.0000000000008590] [Cited by in Crossref: 16] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
135 Boese AC, Hamblin MH, Lee JP. Neural stem cell therapy for neurovascular injury in Alzheimer's disease. Exp Neurol 2020;324:113112. [PMID: 31730762 DOI: 10.1016/j.expneurol.2019.113112] [Cited by in Crossref: 16] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
136 Freeze WM, Bacskai BJ, Frosch MP, Jacobs HIL, Backes WH, Greenberg SM, van Veluw SJ. Blood-Brain Barrier Leakage and Microvascular Lesions in Cerebral Amyloid Angiopathy. Stroke 2019;50:328-35. [PMID: 30661497 DOI: 10.1161/STROKEAHA.118.023788] [Cited by in Crossref: 26] [Cited by in F6Publishing: 38] [Article Influence: 8.7] [Reference Citation Analysis]
137 Kollmer M, Close W, Funk L, Rasmussen J, Bsoul A, Schierhorn A, Schmidt M, Sigurdson CJ, Jucker M, Fändrich M. Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer's brain tissue. Nat Commun 2019;10:4760. [PMID: 31664019 DOI: 10.1038/s41467-019-12683-8] [Cited by in Crossref: 154] [Cited by in F6Publishing: 208] [Article Influence: 51.3] [Reference Citation Analysis]
138 Gyanwali B, Shaik MA, Venketasubramanian N, Chen C, Hilal S. Mixed-Location Cerebral Microbleeds: An Imaging Biomarker for Cerebrovascular Pathology in Cognitive Impairment and Dementia in a Memory Clinic Population. JAD 2019;71:1309-20. [DOI: 10.3233/jad-190540] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
139 Wahab KW, Tiwari HK, Ovbiagele B, Sarfo F, Akinyemi R, Traylor M, Rotimi C, Markus HS, Owolabi M. Genetic risk of Spontaneous intracerebral hemorrhage: Systematic review and future directions. J Neurol Sci 2019;407:116526. [PMID: 31669726 DOI: 10.1016/j.jns.2019.116526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
140 Borshchev YY, Uspensky YP, Galagudza MM. Pathogenetic pathways of cognitive dysfunction and dementia in metabolic syndrome. Life Sci 2019;237:116932. [PMID: 31606384 DOI: 10.1016/j.lfs.2019.116932] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
141 Weldon Furr J, Morales-Scheihing D, Manwani B, Lee J, McCullough LD. Cerebral Amyloid Angiopathy, Alzheimer's Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets. Neuromolecular Med 2019;21:369-90. [PMID: 31586276 DOI: 10.1007/s12017-019-08568-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
142 Gavriliuc P, Molad J, Yaghmour N, Honig A, Gomori J, Cohen J, Auriel E, Leker R. Cerebellar hemorrhages in patients with cerebral amyloid angiopathy. Journal of the Neurological Sciences 2019;405:116418. [DOI: 10.1016/j.jns.2019.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
143 Charidimou A, Frosch MP, Al-Shahi Salman R, Baron JC, Cordonnier C, Hernandez-Guillamon M, Linn J, Raposo N, Rodrigues M, Romero JR, Schneider JA, Schreiber S, Smith EE, van Buchem MA, Viswanathan A, Wollenweber FA, Werring DJ, Greenberg SM; International CAA Association. Advancing diagnostic criteria for sporadic cerebral amyloid angiopathy: Study protocol for a multicenter MRI-pathology validation of Boston criteria v2.0. Int J Stroke 2019;14:956-71. [PMID: 31514686 DOI: 10.1177/1747493019855888] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
144 Schreiber S, Wilisch-Neumann A, Schreiber F, Assmann A, Scheumann V, Perosa V, Jandke S, Mawrin C, Carare RO, Werring DJ. Invited Review: The spectrum of age-related small vessel diseases: potential overlap and interactions of amyloid and nonamyloid vasculopathies. Neuropathol Appl Neurobiol 2020;46:219-39. [PMID: 31386773 DOI: 10.1111/nan.12576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
145 Standring OJ, Friedberg J, Tripodis Y, Chua AS, Cherry JD, Alvarez VE, Huber BR, Xia W, Mez J, Alosco ML, Nicks R, Mahar I, Pothast MJ, Gardner HM, Meng G, Palmisano JN, Martin BM, Dwyer B, Kowall NW, Cantu RC, Goldstein LE, Katz DI, Stern RA, McKee AC, Stein TD. Contact sport participation and chronic traumatic encephalopathy are associated with altered severity and distribution of cerebral amyloid angiopathy. Acta Neuropathol 2019;138:401-13. [PMID: 31183671 DOI: 10.1007/s00401-019-02031-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
146 Ter Telgte A, van Leijsen EMC, Wiegertjes K, Klijn CJM, Tuladhar AM, de Leeuw FE. Cerebral small vessel disease: from a focal to a global perspective. Nat Rev Neurol 2018;14:387-98. [PMID: 29802354 DOI: 10.1038/s41582-018-0014-y] [Cited by in Crossref: 105] [Cited by in F6Publishing: 147] [Article Influence: 35.0] [Reference Citation Analysis]
147 van den Brink H, Zwiers A, Switzer AR, Charlton A, McCreary CR, Goodyear BG, Frayne R, Biessels GJ, Smith EE. Cortical Microinfarcts on 3T Magnetic Resonance Imaging in Cerebral Amyloid Angiopathy. Stroke 2018;49:1899-905. [PMID: 29986931 DOI: 10.1161/STROKEAHA.118.020810] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
148 Schelle J, Wegenast-Braun BM, Fritschi SK, Kaeser SA, Jährling N, Eicke D, Skodras A, Beschorner N, Obermueller U, Häsler LM, Wolfer DP, Mueggler T, Shimshek DR, Neumann U, Dodt HU, Staufenbiel M, Jucker M. Early Aβ reduction prevents progression of cerebral amyloid angiopathy. Ann Neurol 2019;86:561-71. [PMID: 31359452 DOI: 10.1002/ana.25562] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
149 Carmona-Iragui M, Videla L, Lleó A, Fortea J. Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosis. Dev Neurobiol 2019;79:716-37. [PMID: 31278851 DOI: 10.1002/dneu.22709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
150 DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegener 2019;14:32. [PMID: 31375134 DOI: 10.1186/s13024-019-0333-5] [Cited by in Crossref: 289] [Cited by in F6Publishing: 567] [Article Influence: 96.3] [Reference Citation Analysis]
151 Akers C, Acosta LMY, Considine C, Claassen D, Kirshner H, Schrag M. Atypical Clinical Manifestations of Cerebral Amyloid Angiopathy. Curr Neurol Neurosci Rep 2019;19:64. [PMID: 31352553 DOI: 10.1007/s11910-019-0981-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
152 Frösen J, Joutel A. Smooth muscle cells of intracranial vessels: from development to disease. Cardiovasc Res 2018;114:501-12. [PMID: 29351598 DOI: 10.1093/cvr/cvy002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
153 Sakai K, Ueda M, Fukushima W, Tamaoka A, Shoji M, Ando Y, Yamada M. Nationwide survey on cerebral amyloid angiopathy in Japan. Eur J Neurol 2019;26:1487-93. [PMID: 31232495 DOI: 10.1111/ene.14031] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
154 Wisniewski T. Follow-up of active Aβ immunization in Alzheimer disease. Nat Rev Neurol 2019;15:495-6. [DOI: 10.1038/s41582-019-0239-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
155 Chantran Y, Capron J, Alamowitch S, Aucouturier P. Anti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications. Front Immunol 2019;10:1534. [PMID: 31333665 DOI: 10.3389/fimmu.2019.01534] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
156 Perani D, Iaccarino L, Lammertsma AA, Windhorst AD, Edison P, Boellaard R, Hansson O, Nordberg A, Jacobs AH; IMBI Project. A new perspective for advanced positron emission tomography-based molecular imaging in neurodegenerative proteinopathies. Alzheimers Dement 2019;15:1081-103. [PMID: 31230910 DOI: 10.1016/j.jalz.2019.02.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
157 van Veluw SJ, Scherlek AA, Freeze WM, Ter Telgte A, van der Kouwe AJ, Bacskai BJ, Frosch MP, Greenberg SM. Different microvascular alterations underlie microbleeds and microinfarcts. Ann Neurol 2019;86:279-92. [PMID: 31152566 DOI: 10.1002/ana.25512] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
158 Reyes R, Viswanathan M, Aiyagari V. An update on neurocritical care for intracerebral hemorrhage. Expert Rev Neurother 2019;19:557-78. [PMID: 31092052 DOI: 10.1080/14737175.2019.1618709] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
159 Sembill JA, Kuramatsu JB, Schwab S, Huttner HB. Resumption of oral anticoagulation after spontaneous intracerebral hemorrhage. Neurol Res Pract 2019;1:12. [PMID: 33324878 DOI: 10.1186/s42466-019-0018-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
160 den Haan J, van de Kreeke JA, van Berckel BN, Barkhof F, Teunissen CE, Scheltens P, Verbraak FD, Bouwman FH. Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease? Alzheimers Dement (Amst) 2019;11:383-91. [PMID: 31193094 DOI: 10.1016/j.dadm.2019.03.006] [Cited by in Crossref: 22] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
161 Chen SJ, Tsai HH, Tsai LK, Tang SC, Lee BC, Liu HM, Yen RF, Jeng JS. Advances in cerebral amyloid angiopathy imaging. Ther Adv Neurol Disord 2019;12:1756286419844113. [PMID: 31105769 DOI: 10.1177/1756286419844113] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
162 Ii Y, Maeda M, Ishikawa H, Ito A, Matsuo K, Umino M, Shindo A, Kida H, Satoh M, Niwa A, Taniguchi A, Tomimoto H. Cortical microinfarcts in patients with multiple lobar microbleeds on 3 T MRI. J Neurol 2019;266:1887-96. [DOI: 10.1007/s00415-019-09350-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
163 Gkanatsiou E, Portelius E, Toomey CE, Blennow K, Zetterberg H, Lashley T, Brinkmalm G. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer’s disease. Neuroscience Letters 2019;701:125-31. [DOI: 10.1016/j.neulet.2019.02.033] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
164 Inoue T, Saito S, Tanaka M, Yamakage H, Kusakabe T, Shimatsu A, Ihara M, Satoh-Asahara N. Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy. Proc Natl Acad Sci U S A 2019;116:10031-8. [PMID: 31036637 DOI: 10.1073/pnas.1901659116] [Cited by in Crossref: 15] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
165 Das AS, Regenhardt RW, Vernooij MW, Blacker D, Charidimou A, Viswanathan A. Asymptomatic Cerebral Small Vessel Disease: Insights from Population-Based Studies. J Stroke 2019;21:121-38. [PMID: 30991799 DOI: 10.5853/jos.2018.03608] [Cited by in Crossref: 32] [Cited by in F6Publishing: 46] [Article Influence: 10.7] [Reference Citation Analysis]
166 Camacho J, Moliné T, Bonaterra-Pastra A, Ramón Y Cajal S, Martínez-Sáez E, Hernández-Guillamon M. Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy. Front Neurol 2019;10:187. [PMID: 30918495 DOI: 10.3389/fneur.2019.00187] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
167 Dewey CW, Davies ES, Xie H, Wakshlag JJ. Canine Cognitive Dysfunction: Pathophysiology, Diagnosis, and Treatment. Vet Clin North Am Small Anim Pract 2019;49:477-99. [PMID: 30846383 DOI: 10.1016/j.cvsm.2019.01.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
168 Charidimou A, Boulouis G, Roongpiboonsopit D, Xiong L, Pasi M, Schwab KM, Rosand J, Gurol ME, Greenberg SM, Viswanathan A. Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis. Int J Stroke 2019;14:723-33. [PMID: 30785378 DOI: 10.1177/1747493019830065] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
169 Kuramatsu JB, Huttner HB. Management of oral anticoagulation after intracerebral hemorrhage. Int J Stroke 2019;14:238-46. [PMID: 30762497 DOI: 10.1177/1747493019828555] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
170 Pétrault M, Casolla B, Ouk T, Cordonnier C, Bérézowski V. Cerebral microbleeds: Beyond the macroscope. International Journal of Stroke 2019;14:468-75. [DOI: 10.1177/1747493019830594] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
171 Tsai HH, Pasi M, Tsai LK, Chen YF, Lee BC, Tang SC, Fotiadis P, Huang CY, Yen RF, Jeng JS, Gurol ME. Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds: A PiB-PET study. Neurology 2019;92:e774-81. [PMID: 30674594 DOI: 10.1212/WNL.0000000000006953] [Cited by in Crossref: 27] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
172 Wollenweber FA, Opherk C, Zedde M, Catak C, Malik R, Duering M, Konieczny MJ, Pascarella R, Samões R, Correia M, Martí-Fàbregas J, Linn J, Dichgans M. Prognostic relevance of cortical superficial siderosis in cerebral amyloid angiopathy. Neurology 2019;92:e792-801. [PMID: 30674596 DOI: 10.1212/WNL.0000000000006956] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 6.0] [Reference Citation Analysis]
173 Yamada S, Ishikawa M, Yamamoto K, Yamaguchi M, Oshima M. Location-specific characteristics of perivascular spaces as the brain's interstitial fluid drainage system. J Neurol Sci 2019;398:9-15. [PMID: 30665070 DOI: 10.1016/j.jns.2019.01.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
174 Purro SA, Farrow MA, Linehan J, Nazari T, Thomas DX, Chen Z, Mengel D, Saito T, Saido T, Rudge P, Brandner S, Walsh DM, Collinge J. Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone. Nature 2018;564:415-9. [PMID: 30546139 DOI: 10.1038/s41586-018-0790-y] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 18.0] [Reference Citation Analysis]
175 Zhang H, Jin B, Faber JE. Mouse models of Alzheimer's disease cause rarefaction of pial collaterals and increased severity of ischemic stroke. Angiogenesis 2019;22:263-79. [PMID: 30519973 DOI: 10.1007/s10456-018-9655-0] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 8.0] [Reference Citation Analysis]
176 Zhang X, Su J, Gao C, Ni W, Gao X, Li Y, Zhang J, Lei Y, Gu Y. Progression in Vascular Cognitive Impairment: Pathogenesis, Neuroimaging Evaluation, and Treatment. Cell Transplant 2019;28:18-25. [PMID: 30488737 DOI: 10.1177/0963689718815820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
177 Freeze WM, Jacobs HIL, Schreuder FHBM, van Oostenbrugge RJ, Backes WH, Verhey FR, Klijn CJM. Blood-Brain Barrier Dysfunction in Small Vessel Disease Related Intracerebral Hemorrhage. Front Neurol 2018;9:926. [PMID: 30483207 DOI: 10.3389/fneur.2018.00926] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
178 Jandke S, Garz C, Schwanke D, Sendtner M, Heinze HJ, Carare RO, Schreiber S. The association between hypertensive arteriopathy and cerebral amyloid angiopathy in spontaneously hypertensive stroke-prone rats. Brain Pathol 2018;28:844-59. [PMID: 30062722 DOI: 10.1111/bpa.12629] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
179 Tuttolomondo A, Maugeri R, Orlando E, Giannone G, Ciccia F, Rizzo A, Di Raimondo D, Graziano F, Pecoraro R, Maida C, Simonetta I, Cirrincione A, Portelli F, Corpora F, Iacopino DG, Pinto A. β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage. Oncotarget 2018;9:34699-707. [PMID: 30410670 DOI: 10.18632/oncotarget.26165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
180 Charidimou A, Giese AK, Pasi M, van Veluw SJ, Xiong L, Fotiadis P, Marini S, Schirmer MD, Viswanathan A. Journal Club: Florbetapir imaging in cerebral amyloid angiopathy-related hemorrhages. Neurology 2018;91:574-7. [PMID: 30224502 DOI: 10.1212/WNL.0000000000006195] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
181 Cannistraro RJ, Meschia JF. The Clinical Dilemma of Anticoagulation Use in Patients with Cerebral Amyloid Angiopathy and Atrial Fibrillation. Curr Cardiol Rep 2018;20. [DOI: 10.1007/s11886-018-1052-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
182 Ding L, Peng B. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a systematic review and meta‐analysis. Eur J Neurol 2018;25:1276-84. [DOI: 10.1111/ene.13695] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
183 Ishikawa H, Ii Y, Niwa A, Shindo A, Ito A, Matsuura K, Sasaki R, Uno K, Maeda M, Tomimoto H. Comparison of Premortem Magnetic Resonance Imaging and Postmortem Autopsy Findings of a Cortical Microinfarct. J Stroke Cerebrovasc Dis 2018;27:2623-6. [PMID: 29970322 DOI: 10.1016/j.jstrokecerebrovasdis.2018.05.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
184 Wermer MJH, Greenberg SM. The growing clinical spectrum of cerebral amyloid angiopathy. Curr Opin Neurol 2018;31:28-35. [PMID: 29120920 DOI: 10.1097/WCO.0000000000000510] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
185 Weber SA, Patel RK, Lutsep HL. Cerebral amyloid angiopathy: diagnosis and potential therapies. Expert Review of Neurotherapeutics 2018;18:503-13. [DOI: 10.1080/14737175.2018.1480938] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
186 Hecht M, Krämer LM, von Arnim CAF, Otto M, Thal DR. Capillary cerebral amyloid angiopathy in Alzheimer's disease: association with allocortical/hippocampal microinfarcts and cognitive decline. Acta Neuropathol 2018;135:681-94. [PMID: 29574591 DOI: 10.1007/s00401-018-1834-y] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 12.0] [Reference Citation Analysis]
187 Alamowitch S, Capron J. Angiopathie amyloïde cérébrale sporadique. Pratique Neurologique - FMC 2018;9:122-31. [DOI: 10.1016/j.praneu.2018.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
188 van Leijsen EMC, Kuiperij HB, Kersten I, Bergkamp MI, van Uden IWM, Vanderstichele H, Stoops E, Claassen JAHR, van Dijk EJ, de Leeuw FE, Verbeek MM. Plasma Aβ (Amyloid-β) Levels and Severity and Progression of Small Vessel Disease. Stroke 2018;49:884-90. [PMID: 29540613 DOI: 10.1161/STROKEAHA.117.019810] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
189 Koncz R, Sachdev PS. Are the brain's vascular and Alzheimer pathologies additive or interactive? Current Opinion in Psychiatry 2018;31:147-52. [DOI: 10.1097/yco.0000000000000395] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
190 Stefanova NA, Maksimova KY, Rudnitskaya EA, Muraleva NA, Kolosova NG. Association of cerebrovascular dysfunction with the development of Alzheimer's disease-like pathology in OXYS rats. BMC Genomics 2018;19:75. [PMID: 29504901 DOI: 10.1186/s12864-018-4480-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
191 Charidimou A, Friedrich JO, Greenberg SM, Viswanathan A. Core cerebrospinal fluid biomarker profile in cerebral amyloid angiopathy: A meta-analysis. Neurology 2018;90:e754-62. [PMID: 29386280 DOI: 10.1212/WNL.0000000000005030] [Cited by in Crossref: 36] [Cited by in F6Publishing: 44] [Article Influence: 9.0] [Reference Citation Analysis]
192 Charidimou A, Shoamanesh A, Al-Shahi Salman R, Cordonnier C, Perry LA, Sheth KN, Biffi A, Rosand J, Viswanathan A. Cerebral amyloid angiopathy, cerebral microbleeds and implications for anticoagulation decisions: The need for a balanced approach. Int J Stroke 2018;13:117-20. [PMID: 29125055 DOI: 10.1177/1747493017741384] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
193 Charidimou A, Farid K, Tsai H, Tsai L, Yen R, Baron J. Amyloid-PET burden and regional distribution in cerebral amyloid angiopathy: a systematic review and meta-analysis of biomarker performance. J Neurol Neurosurg Psychiatry 2018;89:410-7. [DOI: 10.1136/jnnp-2017-316851] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
194 Boulouis G, Edjlali-Goujon M, Moulin S, Ben Hassen W, Naggara O, Oppenheim C, Cordonnier C. MRI for in vivo diagnosis of cerebral amyloid angiopathy: Tailoring artifacts to image hemorrhagic biomarkers. Rev Neurol (Paris) 2017;173:554-61. [PMID: 28987481 DOI: 10.1016/j.neurol.2017.09.004] [Reference Citation Analysis]
195 Iadecola C. The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease. Neuron 2017;96:17-42. [PMID: 28957666 DOI: 10.1016/j.neuron.2017.07.030] [Cited by in Crossref: 661] [Cited by in F6Publishing: 787] [Article Influence: 132.2] [Reference Citation Analysis]
196 Buchman AS, Leurgans SE, Nag S, VanderHorst VGJM, Kapasi A, Schneider JA, Bennett DA. Spinal Arteriolosclerosis Is Common in Older Adults and Associated With Parkinsonism. Stroke 2017;48:2792-8. [PMID: 28931619 DOI: 10.1161/STROKEAHA.117.017643] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
197 Charidimou A, Blacker D, Viswanathan A. Context is everything: From cardiovascular disease to cerebral microbleeds. Int J Stroke 2018;13:6-10. [PMID: 28906204 DOI: 10.1177/1747493017730907] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
198 Li JM, Huang LL, Liu F, Tang BS, Yan XX. Can brain impermeable BACE1 inhibitors serve as anti-CAA medicine? BMC Neurol 2017;17:163. [PMID: 28841840 DOI: 10.1186/s12883-017-0942-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
199 Boulouis G, Charidimou A, Pasi M, Roongpiboonsopit D, Xiong L, Auriel E, van Etten ES, Martinez-Ramirez S, Ayres A, Vashkevich A, Schwab KM, Rosand J, Goldstein JN, Gurol ME, Greenberg SM, Viswanathan A. Hemorrhage recurrence risk factors in cerebral amyloid angiopathy: Comparative analysis of the overall small vessel disease severity score versus individual neuroimaging markers. J Neurol Sci 2017;380:64-7. [PMID: 28870591 DOI: 10.1016/j.jns.2017.07.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]